Hydralazine tablet labels and packages: Difference between revisions
No edit summary |
|||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
== | ==Labels and Packages== | ||
PRINCIPAL DISPLAY PANEL | PRINCIPAL DISPLAY PANEL |
Revision as of 20:17, 12 March 2014
Hydralazine |
---|
HYDRALAZINE tablet® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Labels and Packages |
HYDRALAZINE injection® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Labels and Packages |
Clinical Trials on Hydralazine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL
Hydralazine Hydrochloride Tablets USP 10 mg 100s Label Text
NDC 50111-398-01
HydrALAZINE HYDROCHLORIDE Tablets USP 10 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
Hydralazine Hydrochloride Tablets USP 25 mg 100s Label Text
NDC 50111-327-01
HydrALAZINE HYDROCHLORIDE Tablets USP 25 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
Hydralazine Hydrochloride Tablets USP 50 mg 100s Label Text
NDC 50111-328-01
HydrALAZINE HYDROCHLORIDE Tablets USP 50 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
Hydralazine Hydrochloride Tablets USP 100 mg 100s Label Text
NDC 50111-397-01
HydrALAZINE HYDROCHLORIDE Tablets USP 100 mg
Rx only
100 TABLETS
TEVA[1]
References
- ↑ "HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.]". Retrieved 10 March 2014.